Clinical Trial Update: A New Strategy Regarding Discontinuation of Dual Antiplatelet [Phase 4]

View source ↗

Summary

Phase 4 trial assessing a new strategy for discontinuing dual antiplatelet therapy in coronary artery disease patients has completed. The study's results are no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Yonsei University | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED